GlassScriptPhysician profile
Corey James Buckley
NPI 1407534555
$730.54
in general payments reported to CMS, 2019-2025
17 companies · $731 in 2025
The $731 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $152.38 | 2025 | Repatha, Otezla |
| Exact Sciences Corporation | $148.41 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lilly USA, LLC | $75.73 | 2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $57.29 | 2025 | Nexletol |
| Abbvie INC. | $49.35 | 2025 | |
| Recor Medical INC | $33.58 | 2025 | Paradise Ultrasound Renal Denervation System |
| Sanofi-Aventis U.S. LLC | $24.98 | 2025 | |
| Novo Nordisk INC | $22.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.79 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.04 | 2025 | Airsupra |
| Pfizer INC. | $20.27 | 2025 | |
| Sumitomo Pharma America, INC. | $19.84 | 2025 | Gemtesa |
| Optinose US, INC. | $18.20 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.08 | 2025 | Zoryve |
| Currax Pharmaceuticals LLC | $17.24 | 2025 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $14.72 | 2025 | Jatenzo |
| Glaxosmithkline, LLC. | $13.78 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.